http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0949507-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_975c4266f8a49abcf34dd5d54f8f5bd5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 1997-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_447d0d0eea73cc2e9b79335f91db4649 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2185645bcfc6ac995a63387e495aa24c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eb54e04fa18772ca08c09177370c407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f70c9994e87fa37ef31f58709f3ebb8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42810e5ae0646045542715c4f87b8bba |
| publicationDate | 1999-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0949507-A1 |
| titleOfInvention | Agent for treating urine specimen |
| abstract | Urine precipitates are frequently formed upon urinenstorage and the precipitate is a big obstacle for conductingnan accurate assay and for sampling a large number of samplesnbecause minor constituents, such as analytes to be measured bynimmunoassay, biochemical assay, etc., are possibly incorporatedninto the precipitate. The present invention provides an agentnfor treating urine for solving the problem of the precipitatenformed during storage of the urine and also provides a methodntherefor. When urine is treated with an agent for treatingnthe urine sample where said agent contains a buffer in the pHnrange of 6.5 or more, the precipitate which is nformed by storing the urine can be solubilized. Saidnprecipitate can also be solubilized by making the pH ofnurine 6.5 or more. In addition, when the precipitate formed bynstoring the urine is solubilized or said formation is inhibitednor prevented, it is now possible to subject a large number ofnsamples to assay by an easy operation even on a mass scalenwhereby a correct and clinically significant result can benobtained. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11592372-B2 |
| priorityDate | 1996-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.